Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adverse events occurring after smallpox vaccination.

J Michael Lane1, Joel Goldstein

  • 1Department of Family and Preventive Medicine, Emory University School of Medicine, 869 Clifton Road, Atlanta, GA 30307, USA.

Seminars in Pediatric Infectious Diseases
|August 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX-622.

Allergy·2025
Same author

Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study.

Allergy·2022
Same author

[COGERIA: coordination of care for the frail elderly].

Revue medicale suisse·2021
Same author

A Study of the Radiation Tolerance of CVD Diamond to 70 MeV Protons, Fast Neutrons and 200 MeV Pions.

Sensors (Basel, Switzerland)·2020
Same author

Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy.

Cancer immunology, immunotherapy : CII·2020
Same author

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy.

Cancer immunology, immunotherapy : CII·2018

Smallpox vaccination can cause serious adverse events, especially in vaccinia-naïve individuals. Risks include central nervous system disease and eczema vaccinatum, with potential for increased fatalities in today's population.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Public Health

Background:

  • Smallpox vaccination was a critical public health measure.
  • A significant portion of the current US population is vaccinia-naïve.
  • Understanding adverse events is crucial for risk assessment.

Purpose of the Study:

  • To review and describe adverse events following smallpox vaccination.
  • To characterize the clinical features of various post-vaccinial complications.
  • To assess the historical and potential current risks associated with smallpox vaccination.

Main Methods:

  • Literature review of reported adverse events.
  • Description of clinical presentations of specific complications.
  • Analysis of historical fatality rates.

Related Experiment Videos

Main Results:

  • Common adverse events include rashes.
  • Serious adverse events include postvaccinial central nervous system disease, progressive vaccinia, eczema vaccinatum, and accidental implantations.
  • Historical fatality rates were low (approx. 1 in a million primary vaccinations).

Conclusions:

  • The vaccinia-naïve population faces risks from smallpox vaccination.
  • Increased prevalence of immune deficiency and atopic dermatitis may elevate current mortality risks.
  • Careful consideration of risks versus benefits is warranted.